Pharmacotherapy of Premenstrual, Perimenopausal, and Postpartum Depression

These slides are from a presentation that articulates the criteria for diagnosis of PMDD and options for treatment, describes prevalence of depression in pregnancy and postpartum and management considerations related to pregnancy and breastfeeding, utilizes the Edinburgh Postnatal Depression Scale to screen for depressive symptoms in perinatal and postpartum women, and explains the factors important in identification and treatment of perimenopausal depression.
Anita Clayton, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.34 MB
Released: December 8, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Intra-Cellular Therapies, Inc.
Neurocrine Biosciences, Inc.
Sage Therapeutics
Sunovion
Supernus Pharmaceuticals, Inc.

Related Content

Expert guidance on accurately diagnosing bipolar depression in patients who may not present in a manic or hypomanic episode from Clinical Care Options (CCO)

Greg W. Mattingly, MD Released: July 6, 2022

Slides from a presentation that educates clinicians on the identification and management of tardive dyskinesia.

Christoph U. Correll, MD Robert O. Cotes, MD Released: May 11, 2022

Slides from a presentation that educates clinicians on antipsychotic treatment of schizophrenia.

Christoph U. Correll, MD Robert O. Cotes, MD Released: May 11, 2022

Slides from a presentation that educates clinicians on managing major depression.

Manish Jha, MD Greg W. Mattingly, MD Released: May 11, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings